. 2017 Jun 29;8(57):97613–97622. doi: 10.18632/oncotarget.18811
Copyright: © 2017 Zheng et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 2. OS and TTP curves of TACE and TACE + sorafenib group.
